Back to Results

LifeMD Inc Preferred Series A (LFMDP)

LifeMD Inc Preferred Series A (NASDAQ: LFMD.P) is a preferred security linked to LifeMD, Inc., a direct-to-patient telehealth company based in New York, New York. The underlying business provides virtual medical care and pharmacy-related services in the United States through a telehealth platform that includes Rex MD, a men’s health service, ShapiroMD, which focuses on hair-loss treatment, and LifeMD PC, a virtual primary care and telehealth offering. Its services also include on-demand consultations, prescriptions, diagnostics and imaging, wellness coaching, in-home tools integration, GLP-1 weight-management support, and in-home health monitoring devices. Founded in 1994, the company was formerly known as Conversion Labs, Inc. and adopted the LifeMD name in February 2021.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-LFMD.P
$32.39
38.7% Upside
Undervalued
—
—
—
Good
—
—
2.22
9.5%
August 7, 2026
-9.7x
13.7x
1.1x
208.9 M
177.7 M
2.9%
82.9%
-0.9
54.8%
-29.3%
Send a message
Valuation • Fair Value

LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) Fair Value by Valuation Model

Compare the primary fair value estimate for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$32.39

Estimated upside of 38.7% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$40.51

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$27.72

Earnings power value estimate.

Comps Fair Value

$29.12

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

193.3 M

Current operating scale indicator.

Revenue Forecast

221.9 M

Forward revenue estimate.

EBITDA

-14.298 M

Current operating profitability reference.

EBITDA Forecast

13.2 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-4.54

No elevated caution signal from this screen.

Altman Z-Score

-0.9

Lower score that deserves closer risk review.

FCF / Net Income

-29.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 7, 2026

Days to Earnings

17

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

9.5%

Income yield reference.

Upcoming Dividend

2.22

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

54.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) Stock Forecast & Technical Outlook

Review LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) Stock FAQ

Quick answers about LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$32.39
Estimated upside 38.7%
Valuation Rating
Undervalued
Estimated upside of 38.7%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is $32.39. This implies an estimated upside of 38.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 38.7% versus the current market price.

An analyst price target for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is not currently available in the latest data file.

The current financial health read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is August 7, 2026.

Based on the current data, dividend yield is 9.5%, upcoming dividend amount is 2.22.

The current P/E ratio listed for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is -9.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for LifeMD Inc Preferred Series A is 208.9 M.

The current enterprise value listed for LifeMD Inc Preferred Series A is 177.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for LifeMD Inc Preferred Series A is NASDAQ-LFMD.P, and the stock is listed on NASDAQ.

LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for LifeMD Inc Preferred Series A is 2.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for LifeMD Inc Preferred Series A is 82.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NASDAQ View more

Waystar Holding Corp (WAY) Waystar Holding Corp (WAY)
Heartflow Inc (HTFL) Heartflow Inc (HTFL)
Schrodinger Inc (SDGR) Schrodinger Inc (SDGR)
Certara Inc (CERT) Certara Inc (CERT)
Goodrx Holdings Inc (GDRX) Goodrx Holdings Inc (GDRX)
HealthStream Inc (HSTM) HealthStream Inc (HSTM)
Sophia Genetics SA (SOPH) Sophia Genetics SA (SOPH)
Trubridge Inc (TBRG) Trubridge Inc (TBRG)
Simulations Plus Inc (SLP) Simulations Plus Inc (SLP)
LifeMD Inc (LFMD) LifeMD Inc (LFMD)
Health Catalyst Inc (HCAT) Health Catalyst Inc (HCAT)
OPTIMIZERx Corp (OPRX) OPTIMIZERx Corp (OPRX)
Definitive Healthcare Corp (DH) Definitive Healthcare Corp (DH)
CareCloud Inc (CCLD) CareCloud Inc (CCLD)
DarioHealth Corp (DRIO) DarioHealth Corp (DRIO)
Onemednet Corp (ONMD) Onemednet Corp (ONMD)
ITonic Holdings Ltd (ITOC) ITonic Holdings Ltd (ITOC)
Firefly Neuroscience Inc (AIFF) Firefly Neuroscience Inc (AIFF)
Scienture Holdings Inc (SCNX) Scienture Holdings Inc (SCNX)
BullFrog AI Holdings Inc Unit (BFRG) BullFrog AI Holdings Inc Unit (BFRG)
Aclarion Inc (ACON) Aclarion Inc (ACON)
Vsee Health Inc (VSEE) Vsee Health Inc (VSEE)
Healthcare Triangle Inc (HCTI) Healthcare Triangle Inc (HCTI)
ISpecimen Inc (ISPC) ISpecimen Inc (ISPC)